Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study

Journal of Psychiatric Research

Volumn 46, Issue 8, 2012, Pages 1099-1105

  Caseiro, Olalla ^a   Pérez Iglesias, Rocío ^a,b   Mata, Ignacio ^a,b   Martínez Garcia, Obdulia ^a   Pelayo Terán, Jose Maria ^a   Tabares Seisdedos, Rafael ^c   Ortiz García de la Foz, Victor ^a,b   Vázquez Barquero, José L ^a,b   Crespo Facorro, Benedicto ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adherence; Antipsychotics; Predictors; Psychosis

Indexed keywords

CLONAZEPAM; HALOPERIDOL; LORMETAZEPAM; OLANZAPINE; RISPERIDONE;

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; EARLY INTERVENTION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONSET AGE; OPEN STUDY; PATIENT COMPLIANCE; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; STATISTICAL SIGNIFICANCE;

EID: 84863433133     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.05.001     Document Type: Article

References (39)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. British Journal of Psychiatry Supplement 1993, 39-44.
2. Altamura A.C., Bassetti R., Sassella F., Salvadori D., Mundo E. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophrenia Research 2001, 52:29-36.
3. Amador X.F., Flaum M., Andreasen N.C., Strauss D.H., Yale S.A., Clark S.C., et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Archives of General Psychiatry 1994, 51:826-836.
4. Andreasen N.C. Scale for the assessment of negative symptoms (SANS) 1983, University of Iowa, Iowa City.
5. Andreasen N.C. Scale for the assessment of positive symptoms (SAPS) 1984, University of Iowa, Iowa City.
6. Barnes T.R. A rating scale for drug-induced akathisia. British Journal of Psychiatry 1989, 154:672-676.
7. Coldham E.L., Addington J., Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 2002, 106:286-290.
8. Craig T.K., Garety P., Power P., Rahaman N., Colbert S., Fornells-Ambrojo M., et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal 2004, 329:1067.
9. Crespo-Facorro B., Perez-Iglesias R., Gonzalez-Blanch C., Mata I. Treatment of the first episode of schizophrenia: an update on pharmacologic and psychological interventions. Current Psychiatry Reports 2008, 10:202-209.
10. Crespo-Facorro B., Perez-Iglesias R., Mata I., Caseiro O., Martinez-Garcia O., Pardo G., et al. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. Journal of Psychiatric Research 2011, 45:763-769.
11. Crow T.J., MacMillan J.F., Johnson A.L., Johnstone E.C. A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 1986, 148:120-127.
12. David A., van Os J., Jones P., Harvey I., Foerster A., Fahy T. Insight and psychotic illness. Cross-sectional and longitudinal associations. British Journal of Psychiatry 1995, 167:621-628.
13. Drake R.J., Dunn G., Tarrier N., Bentall R.P., Haddock G., Lewis S.W. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. Journal of Clinical Psychiatry 2007, 68:81-86.
14. First M.B., Spitzer R.L., Gibbon M., William J.B. Structured clinical interview for DSM-IV-TR Axis I disorders-non-patient edition 2001, Biometrics Research Department, New York.
15. Geddes J., Mercer G., Frith C.D., MacMillan F., Owens D.G., Johnstone E.C. Prediction of outcome following a first episode of schizophrenia. A follow-up study of Northwick Park first episode study subjects. British Journal of Psychiatry 1994, 165:664-668.
16. Gilbert P.L., Harris M.J., McAdams L.A., Jeste D.V. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Archives of General Psychiatry 1995, 52:173-188.
17. Gleeson J.F., Alvarez-Jimenez M., Cotton S.M., Parker A.G., Hetrick S. A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophrenia Research 2010, 119:79-88.
18. Guy W. ECDEU assessment manual for psychopharmacology: Publication ADM 76-338 1976, US Department of Health, Education, and Welfare, Washington (DC), pp. 217-222.
19. Hides L., Dawe S., Kavanagh D.J., Young R.M. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. British Journal of Psychiatry 2006, 189:137-143.
20. Hogarty G.E., Ulrich R.F. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment. Journal of Psychiatric Research 1998, 32:243-250.
21. Kane J.M., Rifkin A., Quitkin F., Nayak D., Ramos-Lorenzi J. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Archives of General Psychiatry 1982, 39:70-73.
22. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica Supplement 1987, 334:1-100.
23. Linszen D., Lenior M., De Haan L., Dingemans P., Gersons B. Early intervention, untreated psychosis and the course of early schizophrenia. British Journal of Psychiatry Supplement 1998, 172:84-89.
24. Linszen D.H., Dingemans P.M., Lenior M.E., Scholte W.F., de Haan L., Goldstein M.J. Early detection and intervention in schizophrenia. International Clinical Psychopharmacology 1998, 13(Suppl. 3):S31-S34.
25. Malla A., Norman R., Bechard-Evans L., Schmitz N., Manchanda R., Cassidy C. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychological Medicine 2008, 38:1585-1593.
26. Miller I.W., Bishop S., Norman W.H., Maddever H. The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Research 1985, 14:131-142.
27. Novak-Grubic V., Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. European Psychiatry 2002, 17:148-154.
28. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:799-812.
29. Pelayo-Teran J.M., Perez-Iglesias R., Ramirez-Bonilla M., Gonzalez-Blanch C., Martinez-Garcia O., Pardo-Garcia G., et al. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Intervention in Psychiatry 2008, 2:178-187.
30. Petersen L., Nordentoft M., Jeppesen P., Ohlenschaeger J., Thorup A., Christensen T.O., et al. Improving 1-year outcome in first-episode psychosis: OPUS trial. British Journal of Psychiatry Supplement 2005, 48:s98-103.
31. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 1999, 56:241-247.
32. Schooler N.R. Relapse and rehospitalization: comparing oral and depot antipsychotics. Journal of Clinical Psychiatry 2003, 64(Suppl. 16):14-17.
33. Simpson G.M., Angus J.W. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplement 1970, 212:11-19.
34. Ucok A., Polat A., Cakir S., Genc A. One year outcome in first episode schizophrenia. Predictors of relapse. European Archives of Psychiatry and Clinical Neuroscience 2006, 256:37-43.
35. Ucok A., Serbest S., Kandemir P.E. Remission after first-episode schizophrenia: results of a long-term follow-up. Psychiatry Research 2011, 189:33-37.
36. Wade D., Harrigan S., Edwards J., Burgess P.M., Whelan G., McGorry P.D. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry 2006, 189:229-234.
37. Weiden P.J., Olfson M. Cost of relapse in schizophrenia. Schizophrenia Bulletin 1995, 21:419-429.
38. Wyatt R.J. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 1991, 17:325-351.
39. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:429-435.